Some insights into the ability of the cancer cell (modeled here with the mock-treated cell lines) to survive and proliferate—starkly contrasted by the cellular senescence within few days following SMARCB1 rescue—came instead from our investigation into the role of ncBAF subunit BRD9 in the mock-treated cells. The gene discussed is SMARCB1; the disease is cancer.